"Trypanosoma cruzi" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors.
| Descriptor ID |
D014349
|
| MeSH Number(s) |
B01.268.475.868.887.140
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Trypanosoma cruzi".
Below are MeSH descriptors whose meaning is more specific than "Trypanosoma cruzi".
This graph shows the total number of publications written about "Trypanosoma cruzi" by people in this website by year, and whether "Trypanosoma cruzi" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 4 | 1 | 5 |
| 2014 | 6 | 3 | 9 |
| 2015 | 6 | 1 | 7 |
| 2016 | 5 | 2 | 7 |
| 2017 | 5 | 2 | 7 |
| 2018 | 7 | 2 | 9 |
| 2019 | 2 | 5 | 7 |
| 2020 | 4 | 4 | 8 |
| 2021 | 9 | 2 | 11 |
| 2022 | 8 | 0 | 8 |
| 2023 | 7 | 1 | 8 |
| 2024 | 7 | 2 | 9 |
| 2025 | 6 | 2 | 8 |
| 2026 | 6 | 2 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Trypanosoma cruzi" by people in Profiles.
-
Therapeutic potential of hookworm proteins in promoting regulatory immune responses to modulate Trypanosoma cruzi induced liver inflammation and oxidative stress. Mem Inst Oswaldo Cruz. 2026; 121:e250123.
-
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions. J Clin Invest. 2026 Mar 16; 136(6).
-
Immunotherapy of TSA-1.C4 or in combination with BNZ confers protection against Trypanosoma cruzi infection with a distinct cytokine response. Vaccine. 2026 Mar 19; 76:128296.
-
Chagas and Vector-Borne Disease Exposures in an Indigenous Community in the Ecuadorian Amazon: A Retrospective Study. Am J Trop Med Hyg. 2025 Oct 01; 113(4):806-808.
-
Different responses involving Tfh cells delay parasite-specific antibody production in Trypanosoma cruzi acute experimental models. Front Immunol. 2025; 16:1487317.
-
Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate. PLoS Pathog. 2024 12; 20(12):e1012764.
-
Chronic Chagas Disease in the US. JAMA. 2024 06 18; 331(23):2037-2038.
-
Adaptation of Chagas Disease Screening Recommendations for a Community of At-risk HIV in the United States. Clin Infect Dis. 2024 02 17; 78(2):453-456.
-
Chagas Disease Diagnostic Practices at Four Major Hospital Systems in California and Texas. J Infect Dis. 2024 01 12; 229(1):198-202.
-
The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection. PLoS Negl Trop Dis. 2023 11; 17(11):e0011519.